That equates to 0.8 cases of GBS per million vaccinated, which is a rate similar to that seen with seasonal vaccines in some years, Dr. DeStefano said.
Taken together, the data presented to ACIP on H1N1 flu vaccine safety are remarkably reassuring, according to Dr. Carol Baker, ACIP chair and a pediatric infectious disease specialist at Baylor College of Medicine in Houston.
“I think we have incredibly strong and extensive data on how safe this vaccine is. I hope that everyone that's listening … is very assured by this data,” she said, adding: “I do not know of data that are this strong for any vaccine that we have ever used in our country.”
Disclosures: Dr. DeStefano, Dr. Shay, and Dr. Baker said they had no conflicts of interest. Dr. Lieu said she had none other than that the studies were funded by the CDC and the Food and Drug Administration.